Loxagen, is an innovative biotech with a seasoned development team, a platform technology, near term inflection points with a large market opportunity. Our team is comprised of experienced industry personnel who have taken multiple drugs to the clinic and world-renowned clinicians. With the help of non-dilutive funding, we have completed most of the IND enabling studies for our lead program and raising funds to complete IND submission and Phase 1 clinical studies within 2 years